Diagnostic Overview and Management of Adult Pulmonary Tuberculosis Patients Inpatient at RSU Royal Prima Medan in 2020
DOI:
https://doi.org/10.37275/amcr.v3i1.158Keywords:
Lung Tuberculosis, Mycobacterium Tuberculosis, Descriptive Study, Tuberculosis DrugsAbstract
Tuberculosis is an inflammatory disease of the lung parenchyma caused by infection with Mycobacterium tuberculosis. This research aims to find out the description of the diagnosis and management of adult pulmonary TB patients hospitalized at RSU Royal Prima Medan in 2020. This study is a descriptive study. This study is based on medical record data on inpatients with a diagnosis of pulmonary TB at the Royal Prima General Hospital Medan in 2020. The youngest patient was 18 years old and the oldest was 82 years old. The main complaint was shortness of breath (53%), additional complaints were cough (48%), symmetrical physical examination of the thorax (91%), positive sputum smear examination (72%), combined medical management of pulmicort + fumadryl + paracetamol + levofloxacin + OAT category I (72%), the longest length of stay was 7-8 days (38%), the shortest was 11-12 days (1%). In conclusion, pulmonary TB occurs more in men in the 37- 45 year age group (22%), the most complaints are shortness of breath (53%), and the most widely used combination treatment is pulmicort + fumadryl + paracetamol + levofloxacin + drugs anti tuberculosis category I (72%).
Authors
- Dewi Sartika1*
- Nerseri Barus2
- Sri Lestari Ramadhani Nasution3
- 1Undergraduate Student of Medical Education, Faculty of Medicine, Dentistry and Health Science, Universitas Prima Indonesia, Medan, Indonesia
- 2Department of Public Health, Faculty of Medicine, Dentistry and Health Science, Universitas Prima Indonesia, Medan, Indonesia
- 3Department of Public Health, Faculty of Medicine, Universitas Prima Indonesia, Medan, Indonesia
Corresponding author Dewi Sartika — dewiisartika1902@gmail.com
Downloads
Published
Issue
Section
License
Authors retain copyright and grant Archives of The Medicine and Case Reports (AMCR) the right of first publication. Published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). This license permits users to copy, redistribute, and adapt the work for non-commercial purposes, provided that appropriate credit is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license. Copyright in the journal website, logo, layout, and other publisher-owned materials does not transfer copyright in individual articles.
How to Cite
Article Metrics
Views and downloads recorded by this journal. Citation count from OpenAlex.